January 20, 2006
The United States Anti-Doping Agency (USADA) announced today that Bryan Berard of Columbus, Ohio, an athlete in the sport of ice hockey, has accepted a two-year suspension after his sample collected November 12, 2005, as part of the USADA Out-of-Competition Testing Program tested positive for the prohibited substance 19-norandrosterone.
19-norandrosterone is classified as an anabolic agent under the rules of the International Ice Hockey Federation (IIHF) and USADA, both of which have adopted the World Anti-Doping Agency’s Prohibited List.
Berard will voluntarily cooperate with USADA in its education efforts to inform athletes and the public about the adverse health affects associated with the use of performance enhancing drugs.
Berard’s two-year suspension begins on January 3, 2006, the day he accepted a provisional suspension. USA Hockey, the national governing body for the sport in the United States, will carry out the sanction.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement. USADA is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.